Announcement on Progress in Investment Cooperation with a Private Fund
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Investment Cooperation with a Private Fund
Filed with SSE · · 3 pages · Chinese
Release
Nanjing Pharmaceutical Group Company Limited on 6ix
Earlier from Nanjing Pharmaceutical
- Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
- Indicative Announcement on Stopping Conversion of "NPGC Convertible Bonds" When Implementing Dividend Distribution for 2025
- Announcement on Issuance Result of Phase VIII Ultra-Short-Term Financing Bonds of 2026
- Announcement on Completing the Repurchase and Cancellation of Restricted Stocks without Adjusting Conversion Price of Convertible Bonds
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
Later from Nanjing Pharmaceutical
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Resolutions of the Extraordinary Meeting of the 10th Board of Directors
- Announcement on Progress in External Investment by the Controlled Subsidiary and Signing of Relevant Investment Agreements
- Announcement on the Issuance Results of the 2nd Tranche of Medium-Term Notes for 2026
- Announcement on Redemption upon Maturity of Cash Management Products Purchased by the Company's Subsidiary with Part of Temporarily Idle Raised Funds and Continued Cash Management
Follow Nanjing Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Pharmaceutical